How to cultivate large varieties of Chinese herbal pieces?

According to traditional Chinese medicine on July 31, Chinese medicines have been processed to meet the requirements of the theory and application of Chinese medicinal properties. Since the 2010 edition of the Chinese Pharmacopoeia clearly stipulated that Chinese herbal decoction pieces refer to prescription drugs which can be directly used in clinical or pharmaceutical production after processing, Chinese herbal decoction pieces and Chinese herbal medicines are classified as two independent varieties. Chinese herbal decoction pieces are the material basis of traditional Chinese medicine. The authenticity and quality of Chinese herbal decoction pieces are directly related to the safety, effectiveness and control of clinical medication of traditional Chinese medicine. The healthy development of Chinese herbal decoction industry is of great significance to guarantee the quality of Chinese herbal decoction pieces and clinical safe medication of traditional Chinese medicine. In recent years, with the reform of medical system and the change of people's health concept, the market scale of traditional Chinese medicine decoction industry has been increasing. Affected by the increase of main business income and market scale, the profit of Chinese herbal medicines slices increased, but the added value of Chinese herbal medicines slices products was low, and the profit margin of products was relatively lower than that of Chinese patent medicines.
With the promulgation and revision of the Chinese medicine legislation and the bidding policy for the sale of Chinese herbal medicines, the catalogue of essential medicines and medical insurance, the development policy of Chinese herbal medicines industry is good. In the future, it is possible to implement the approval number management or incorporate some varieties into the Regulations on the Protection of Chinese herbal medicines varieties, which will promote the entry of Chinese herbal medicines industry. One step development. However, affected by the current development problems, such as uneven quality, shortage of raw materials, degradation of planting varieties, non-standardized initial processing and processing, non-uniform commodity specifications and standards, the future of the traditional Chinese medicine decoction industry is still full of uncertainties.
Influenced by low profit margin of traditional Chinese medicine pieces and regional factors of cultivation and production, the concentration of traditional Chinese medicine Pieces industry is generally low, the market circulation is dispersed, and it is difficult to form large circulation, large varieties, large brands and large-scale leaders in traditional Chinese medicine pieces industry. It is difficult for enterprises to cultivate. Some enterprises update their equipment and technology slowly, and even some enterprises are obsolete in production equipment. The lack of research on product upgrading and innovation affects the healthy development of the industry.
Development suggestions for the cultivation of large varieties of traditional Chinese medicine, the author has the following suggestions.
1. Integrating the industrial chain is conducive to the cultivation of large varieties and brands of Chinese herbal slices
The quality of Chinese herbal slices is affected by the upstream industrial chain of planting, harvesting and processing. Simply standardizing the production and processing of Chinese herbal slices obviously can not completely solve the related problems. Integration is conducive to the guarantee of the quality of Chinese herbal pieces. At present, with the increasing standardization of the industry, we should encourage the integration of upstream and downstream industries, merger and acquisition of enterprises, strengthen the control over the source of medicinal materials, and gradually improve the industry concentration. Through the integration of upstream medicinal material planting, production and downstream processing, processing and marketing, the production norms and standards of medicinal material planting, harvesting, preliminary processing, storage and transportation, specifications and grades, and processing of decoction pieces are formulated, so as to form a systematic and traceable production norm and standard system from raw material production to final product, which is convenient for us. Controlling the factors causing the quality change of Chinese herbal pieces and ensuring the uniformity, stability, safety and effectiveness of the quality of Chinese herbal pieces are conducive to cultivating large varieties and brands of Chinese herbal pieces and improving the level of the industry in an all-round way.
2. Develop genuine medicinal materials, cultivate key regional enterprises
In genuine producing areas of Chinese medicinal materials, standardize the technical standards of genuine medicinal materials production, establish the production base of genuine medicinal materials, ensure the quality of medicinal materials, stabilize the quality of medicinal materials and cultivate medicinal pieces with Chinese medicinal materials. The key enterprises in the production capacity of the whole industry chain should concentrate their efforts on developing the dominant genuine medicinal materials or key varieties, promote the standardization, standardization and unification of the production of Chinese medicinal materials and pieces, cultivate industrial and benchmarking varieties, and gradually promote the development of other kinds of Chinese medicinal pieces.
3. Combining the inheritance and innovation of Chinese herbal slices processing, speeding up the formulation of industry standards
Enterprises, governments and research institutions should attach importance to the theoretical research of Chinese herbal slices processing, strengthen the combination of inheritance and innovation of Chinese herbal slices, highlight the combination of theoretical research and practical application, and avoid non-compliance. The theory of traditional Chinese medicine and traditional Chinese medicine processing, as well as the waste caused by blindly innovating according to the relevant laws and regulations of traditional Chinese medicine, should be screened for the inheritance of traditional experience, establish the dialectical academic research thought of "inheriting the old and innovating the old" and enhance the processing and production technology of traditional Chinese medicine pieces, and speed up the production of traditional Chinese medicine and traditional Chinese medicine pieces. Establishment and promotion of industry standards in the fields of production, circulation and use.
Drugs as special commodities, policy orientation has a great impact on industrial development, as an important material basis of traditional Chinese medicine, the development of Chinese medicine should be paid attention to by policy, and gradually explore the management system of approval number of Chinese medicine pieces. In the fields of medical insurance and national basic medical treatment, we should explore policies suitable for promoting the development of traditional Chinese medicine decoction industry. We should guide the enterprises of traditional Chinese medicine decoction pieces to upgrade their industries through policies, strengthen the coordinated development of traditional Chinese medicine decoction pieces and prescription granules, and promote the rational transformation and upgrading of the industry of traditional Chinese medicine decoction pieces.
Looking for chemical products? Let suppliers reach out to you!
2026-06-24
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Chinese Herbal Market Was Hot Last Week
-
Oyin releases herbal hair tonic with frankincense and myrrh
-
Chinese medicine enters the era of plant extraction
-
Drink herbal tea on fire in summer? These people need to drink with caution.
-
₹27,548 Crore Pharma Giant Cipla Enters Weight Management Battle as Obesity Demand Surges
-
60 Percent Workforce Held by Top 10 Firms! China’s TCM Industry Faces Fierce Reshuffle as Private Leaders Expand Fast
-
Vertex Shares Plunge 14.4 Percent After Pain Drug Trial Misses Key Target and Study Halt
-
Syndax Q2 Net Loss Widens to $71.8 Million Despite 43 Percent Revenue Surge and New Drug Momentum
-
Emcure Seals Exclusive Deal for Sanofi’s Oral Diabetes Brands Millions of Indian Patients to Benefit
-
Trump Warns of 200 Percent Tariffs on Pharma Companies by August 1 India Trade Deal Among Top Priorities
Recommend Reading
-
Over 22,000 New Cases in India AstraZeneca Gets CDSCO Green Light for Muscle-Invasive Bladder Cancer Drug
-
AstraZeneca Rare Disease Drug Misses Phase 3 Target Hope Shifts to Subgroup Data
-
Sandoz Set to Slash Canadian Weight-loss Drug Prices by Up to 70 Percent Generics Could Expand Patient Access
-
Pfizer Lifts 2025 Profit Forecast After Q2 Earnings Beat Sales Hit $14.65 Billion Shares Jump 2.8 Percent
-
4 Pharma Firms Lose Licenses in Jammu and Kashmir Amid Illegal Drug Sales Crackdown
-
Air Atmosphere Dominates as Polyester Bottle Flakes Market Weakly Declines
-
Univar Solutions and BASF Expand Distribution Agreement
-
SKC Secures $40 Million IFC Investment for 70,000-Ton Biodegradable PBAT Plant in Vietnam Commercial Launch Set for 2026
-
Premium Global Chemical Sourcing Requests (2-3Jun, 2026)
-
Luoyang Refining’s 2.78 Billion USD Ethylene Project Achieves Full Start-Up Annual Revenue to Hit 1.69 Billion USD